Atlas Trials

Zanubrutinib Induction Followed by Delayed Fixed-Duration Combination With Sonrotoclax for CLL/SLL:Stop Trial 2.0

Clinical trial NCT07682415 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07682415
Sponsor
Yi Shuhua
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
CLL / SLL
Start date
2026-06-08
Primary completion
2029-12-31
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.